LobbyingAmerican College of Clinical Pharmacy lobbying by quarter
American College of Clinical Pharmacy's latest lobbying report covers Q2 2026, at $595K. The four quarters Q4 2025–Q3 2026 total $1.8M. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Health Issues.
American College of Clinical Pharmacy
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $1.8M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $40K | 1 |
| Q1 2023 | $195K | 2 |
| Q2 2023 | $195K | 2 |
| Q3 2023 | $195K | 2 |
| Q4 2023 | $195K | 2 |
| Q1 2024 | $195K | 2 |
| Q2 2024 | $195K | 2 |
| Q3 2024 | $195K | 2 |
| Q4 2024 | $195K | 2 |
| Q1 2025 | $595K | 2 |
| Q2 2025 | $595K | 2 |
| Q3 2025 | $595K | 2 |
| Q4 2025 | $595K | 2 |
| Q1 2026 | $595K | 2 |
| Q2 2026 | $595K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$2.6M · 29 reports
- Health issues$1.3M · 18 reports
- Education$405.9K · 14 reports
- Medical research and clinical labs$405.9K · 14 reports
- Pharmacy$405.9K · 14 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Centers For Medicare and Medicaid Services (CMS)29 reports
- Health & Human Services, Dept of (HHS)29 reports
- HOUSE OF REPRESENTATIVES29 reports
- SENATE29 reports
- Defense, Dept of (DOD)15 reports
- Food & Drug Administration (FDA)14 reports
- Health Resources & Services Administration (HRSA)14 reports
Firms it paid
| Firm | ||
|---|---|---|
| Capitol Advocacy & Government Affairs | $3.1M | 15 quarters |
| In-houseAmerican College of Clinical Pharmacy | $2M | 14 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JOHN MCGLEW | Senior Director, Government Affairs | Q2 2026 |
| KATHERINE D PHAM | Senior Director of Policy and Professional Affairs | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 08/07for Q2 | Capitol Advocacy & Government Affairs | $450K |
| 07/07for Q2 | In-house | $145K |
| 04/20for Q1 | Capitol Advocacy & Government Affairs | $450K |
| 04/06for Q1 | In-house | $145K |
| 02/06for Q4 2025 | Capitol Advocacy & Government Affairs | $450K |
| 01/06for Q4 2025 | In-house | $145K |
| 25/10/20for Q3 2025 | Capitol Advocacy & Government Affairs | $450K |
| 25/10/06for Q3 2025 | In-house | $145K |
| 25/08/05for Q2 2025 | Capitol Advocacy & Government Affairs | $450K |
| 25/07/07for Q2 2025 | In-house | $145K |
| 25/04/21for Q1 2025 | Capitol Advocacy & Government Affairs | $450K |
| 25/04/03for Q1 2025 | In-house | $145K |
| 25/02/04for Q4 2024 | Capitol Advocacy & Government Affairs | $50K |
| 25/01/09for Q4 2024 | In-house | $145K |
| 24/10/09for Q3 2024 | Capitol Advocacy & Government Affairs | $50K |
| 24/10/03for Q3 2024 | In-house | $145K |
| 24/07/09for Q2 2024 | Capitol Advocacy & Government Affairs | $50K |
| 24/07/01for Q2 2024 | In-house | $145K |
| 24/04/25for Q1 2024 | Capitol Advocacy & Government Affairs | $50K |
| 24/04/02for Q1 2024 | In-house | $145K |